Semaglutide use in patients with type 2 diabetes moderately increases the risk of nonarteritic anterior ischemic optic neuropathy.

This requires constant monitoring by anyone who may have neuropathy concerns. For those diagnosed with diabetes, an A1C test should be taken at least twice a year, and a target of 6.5% (or less) ...

Conversely, anhidrosis, or reduced or absent sweating, is less common but may be experienced in the feet or legs of people with diabetic neuropathy. Treatment of excessive sweating depends on the ...

Weight loss drugs like Ozempic, while transformative in combating obesity, have been linked to irreversible vision impairment ...

Polyphenol-rich ginger is our pick for the best spice to help lower blood sugar. Ginger can also positively influence your ...

Credit card debt is a challenge for retirees and those nearing retirement. Many adults 50 and older carry credit card debt or ...

Living with chronic pain can be physically and emotionally draining, but adopting the right strategies can help you regain ...

Ionis Pharmaceuticals IONS announced that the European Commission (“EC”) has approved Wainzua (eplontersen) for treating ...

It is essential to carefully read a supplement's ingredient list and nutrition facts panel to know which ingredients ... 2019.0099 Ogbera A, Oshinaike O, Ezeobi E, Unachukwu C. Treatment of diabetes ...

Adults with type 1 diabetes who initiated treatment with a bionic pancreas at a primary care site experienced similar glycemic benefits as those starting the device through an endocrinologist ...

Prince Frederik of Luxembourg, aged 22, passed away from POLG mitochondrial disease, a rare genetic disorder. His father ...

Guggenheim reiterated their buy rating on shares of Dianthus Therapeutics (NASDAQ:DNTH – Free Report) in a research note released on Wednesday,Benzinga reports. They currently have a $84.00 price ...